3 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Daliresp (Roflumilast ... tablet once daily ... won’t have any clinical ... effect. ... #Indications #Pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Blood Pressure, Pulmonary ... Book of Critical ... #Pharmacology # ... Effect #Management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
but rather as a condition ... with presence of pulmonary ... ECG is vital while ... #differential #algorithm ... #pharmacology